Celldex widens losses

Celldex Therapeutics Inc. (Nasdaq: CLDX) widened losses for the second quarter to 33 cents per share from 32 cents per share in the year ago period sending the stock price plummeting $4.39 to close at $16.96.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.